Cardiff Oncology

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRDF and other ETFs, options, and stocks.

About CRDF

Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. It is focused on developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics. 

CEO
Mark Erlander
CEOMark Erlander
Employees
32
Employees32
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1999
Founded1999
Employees
32
Employees32

CRDF Key Statistics

Market cap
187.34M
Market cap187.34M
Price-Earnings ratio
-4.70
Price-Earnings ratio-4.70
Dividend yield
—
Dividend yield—
Average volume
652.55K
Average volume652.55K
High today
$4.45
High today$4.45
Low today
$4.15
Low today$4.15
Open price
$4.38
Open price$4.38
Volume
213.20K
Volume213.20K
52 Week high
$6.42
52 Week high$6.42
52 Week low
$0.94
52 Week low$0.94
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.